IDD-Xpert
Private Company
Funding information not available
Overview
Founded in 2013 and headquartered in Lyon, France, with a GMP manufacturing facility in Evreux, IDD-Xpert operates as a specialized Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO). It serves over 300 international customers, focusing on innovative drug delivery for small molecules and biologics, with a strong emphasis on powder-based formulations like tablets and inhaled products (pMDIs, sprays). The company's business model is entirely service-based, generating revenue through its R&D platform and manufacturing services for pharmaceutical and cosmetic clients.
Technology Platform
Integrated R&D platform specializing in powder characterization, QbD formulation, process scale-up, and GMP manufacturing for oral and inhaled dosage forms. Combines analytical development, stability testing, and regulatory support.
Opportunities
Risk Factors
Competitive Landscape
IDD-Xpert competes in the fragmented CDMO/CRO market, facing competition from large global players (e.g., Lonza, Catalent) with broader offerings and other specialized European CDMOs focused on formulation. Its differentiation lies in its deep, integrated expertise in powder science and inhaled/oral dosage forms for both pharma and cosmetics.